Tesla (TSLA) stock falls 7.5% as VP Lars Moravy teases July 7 Austin announcement. Q1 revenue missed targets despite earnings beat. What's next for TSLA? The postTesla (TSLA) stock falls 7.5% as VP Lars Moravy teases July 7 Austin announcement. Q1 revenue missed targets despite earnings beat. What's next for TSLA? The post

Tesla (TSLA) Stock Drops 7.5% Ahead of Mystery July 7 Announcement

2026/07/03 18:58
4 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Takeaways

  • Lars Moravy, Tesla’s VP of Vehicle Engineering, hinted at significant announcements coming July 7 regarding scaling initiatives at the Austin, Texas facility
  • Speculation centers on manufacturing updates — potentially Cybercab production milestones, regulatory greenlight, robotics advancements, or Semi developments
  • Shares of TSLA started Friday trading at $393.45, reflecting a 7.49% decline, with year-to-date performance down approximately 6%
  • First quarter 2026 results showed earnings per share of $0.41, surpassing projections, though revenue of $22.39 billion fell short of the $22.96 billion forecast
  • Wall Street maintains a “Hold” rating on average, with price targets centered around $403.92

Shares of Tesla (TSLA) are facing downward momentum entering the Independence Day weekend, though a potential market-moving announcement could shift sentiment early next week.


TSLA Stock Card
Tesla, Inc., TSLA

During a recent investor discussion shared on YouTube, Lars Moravy, who oversees Vehicle Engineering at Tesla, teased that July 7 will bring “cool news” connected to activities at the company’s Austin, Texas manufacturing hub, framing it as integral to Tesla’s expansion strategy.

Moravy offered no specifics. Tesla has not issued a statement in response to media inquiries.

Shares of TSLA began Friday’s session at $393.45, declining 7.49%. After closing the second quarter at $420.60, the electric vehicle maker’s stock has surrendered roughly 6% in 2026, fluctuating between $337.24 and $458.34 during the first six months.

Over the past year, shares have ranged from a low of $288.77 to a high of $498.83. The current price sits beneath both the 50-day moving average of $407.27 and the 200-day moving average of $411.92.

Potential Focus Areas for the July 7 Update

The Cybercab appears to be the prime candidate for Monday’s announcement. Tesla has commenced production of its autonomous robotaxi, engineered without traditional steering wheels or pedals. The update could address production volume achievements or critical road certification in Texas.

Alternative possibilities include developments in humanoid robotics, the Tesla Semi program, or broader vehicle manufacturing initiatives. Moravy has consistently emphasized that Tesla’s manufacturing prowess — the capacity to produce vehicles at scale with superior cost efficiency — represents the company’s fundamental competitive advantage.

He referenced SpaceX as a comparable model, where reusability slashed orbital launch costs by approximately 95% compared to the Space Shuttle era. This cost transformation enabled Starlink’s constellation of roughly 10,000 satellites while generating profit margins exceeding 60%. Tesla aims to replicate this economic framework through affordable Cybercabs and robotic systems.

First Quarter Performance and Wall Street Outlook

Tesla’s first quarter 2026 financial results delivered earnings per share of $0.41, exceeding analyst expectations of $0.39 by $0.02. However, revenue reached $22.39 billion, representing 15.8% year-over-year growth but falling short of the $22.96 billion consensus estimate.

The company posted a return on equity of 4.89% alongside a net margin of 3.95%. Full-year earnings per share projections currently stand at $1.20 according to analyst forecasts.

Wall Street sentiment remains divided. Among 45 analysts surveyed, 21 recommend buying TSLA, 20 suggest holding, and 4 advise selling. The consensus price target of $403.92 trails recent trading levels.

Institutional positioning has been inconsistent. SOL Capital Management dramatically reduced its Tesla holdings by 86.7% during the first quarter, disposing of 8,576 shares while retaining only 1,319. Conversely, Boston Trust Walden expanded its position substantially, increasing holdings by 183.7%. Both Keybank and Stevens Capital also accumulated additional shares.

Executive transactions skewed toward selling activity. Chief Financial Officer Vaibhav Taneja divested 2,606 shares in early June at $402.20, trimming his holdings by 10.57%. Board member Kathleen Wilson-Thompson sold 26,409 shares in late April at $378.11, reducing her stake by 35.3%. Both transactions occurred through predetermined 10b5-1 trading arrangements.

Moravy maintains an optimistic long-term perspective on Tesla’s artificial intelligence roadmap. “The amount of real world AI that’s going to be around you because of Tesla is going to be mind-blowing,” he stated, projecting forward over the coming five years.

Tesla currently commands a market capitalization approaching $1.48 trillion, trading at a price-to-earnings ratio of 360.96.

The post Tesla (TSLA) Stock Drops 7.5% Ahead of Mystery July 7 Announcement appeared first on Blockonomi.

Market Opportunity
Audiera Logo
Audiera Price(BEAT)
$2.70096
$2.70096$2.70096
-0.78%
USD
Audiera (BEAT) Live Price Chart

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.